Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients
NCT ID: NCT03977051
Last Updated: 2024-04-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
26 participants
OBSERVATIONAL
2017-02-08
2017-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Adherence in Nonadherent Kidney Transplant Patients
NCT03892317
Survey of Adherence to Immunosuppression and Other Medications in Kidney Transplant Patients
NCT00433134
Video Education and Behaviour Contract to Optimize Adherence in Renal Transplants
NCT03540121
Measuring and Improving Medication Adherence in Kidney Transplant Patients
NCT02639949
Medication Adherence in Kidney Transplant
NCT06004102
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Focus group
Focus group to explore immunosuppressant medication adherence in kidney transplant patients
Focus group
Kidneys transplant patients will discuss their attitudes and beliefs towards immunosuppressant medication adherence
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Focus group
Kidneys transplant patients will discuss their attitudes and beliefs towards immunosuppressant medication adherence
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Speak and understand English
* 18 years and above
Exclusion Criteria
* Below 18 years
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dawn Goodall, MSC, BSc
Role: PRINCIPAL_INVESTIGATOR
Imperial College Healthcare NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imperial College Renal and Transplant Centre
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16HH3697
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.